The current study analyzed for the first time the adverse effects of GDM on maternal and fetal glomerular podocytes by measuring the urine and amniotic fluid levels of the podocyte-specific proteins pdx and nephrin. This evidence concerns the gene NPHS1 and gestational diabetes.